{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:49:50Z","timestamp":1791560990735,"version":"4.3.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Endometrioid endometrial carcinoma (EEC) is the most common type of endometrial carcinoma. A small subset recurs exclusively in the vagina. Data on this group remain limited due to its low incidence and study heterogeneity, combining different histologies and recurrence sites. We describe 20 patients with isolated vaginal recurrence of EEC, focusing on tumor characteristics, treatment, time to recurrence, and outcomes. Vaginal recurrences occurred between 2015 and 2024. Patients with positive margins at primary surgery or persistent disease were excluded. Medical records and slides were reviewed. Median time to vaginal recurrence was 2\u00a0yr (range, &lt;1\u2013&gt;16\u00a0yr), with 85% occurring within 4\u00a0yr. Most recurrences were unifocal and at the vaginal apex, and all retained the primary tumor grade. High-grade EEC recurred 19 months earlier than low-grade (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0227). Time to vaginal recurrence was not associated with other tumor features or postsurgical management. Complete remission was achieved in 65% of evaluable patients; among complete responders, 82% received radiotherapy (RT) alone. Second vaginal-only recurrences were uncommon (10%), and half were successfully salvaged. Five-year overall survival (OS) after primary tumor diagnosis was 89% (95% CI: 75%\u2013100%) and after vaginal recurrence was 84% (95% CI: 66%\u2013100%). Median follow-up after recurrence was 3.7\u00a0yr (95% CI: 1.0\u20135.7\u00a0yr). OS was associated with FIGO stage (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.0001) and lymphovascular invasion (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.0081). Five-year postrecurrence disease-free survival (PR-DFS) was 68% and was shorter in high-grade tumors (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.043) and in patients receiving adjuvant RT (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.013).\n                  <\/jats:p>","DOI":"10.1097\/pgp.0000000000001195","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:01:20Z","timestamp":1779969680000},"page":"454-461","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Isolated Vaginal Recurrence of Endometrioid Endometrial Carcinoma"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-1832","authenticated-orcid":false,"given":"Sara","family":"da Mata","sequence":"first","affiliation":[{"name":"Department of Pathology, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Mora","sequence":"additional","affiliation":[{"name":"Department of Pathology, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Silva","sequence":"additional","affiliation":[{"name":"NOVA Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Esteves","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas Conde","family":"Vasco","sequence":"additional","affiliation":[{"name":"Department of Radiology, ULS S\u00e3o Jos\u00e9, Hospital Curry Cabral"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Margarida","family":"Cunha","sequence":"additional","affiliation":[{"name":"Department of Radiology, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delfim","family":"Doutel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Department of Pathology, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil"},{"name":"NOVA Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"F\u00e9lix","sequence":"additional","affiliation":[{"name":"Department of Pathology, Instituto Portugu\u00eas de Oncologia de Lisboa Francisco Gentil"},{"name":"NOVA Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1634\/theoncologist.8-6-541","article-title":"Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"8","author":"Gloeckler Ries","year":"2003","journal-title":"Oncologist"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/jnci\/djx214","article-title":"International patterns and trends in endometrial cancer incidence, 1978-2013","volume":"110","author":"Lortet-Tieulent","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"R3-20261009","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2022.11.012","article-title":"Recurrence and survival in endometrioid endometrial cancer\u2014a population-based cohort study","volume":"168","author":"\u00c5kesson","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ygyno.2012.12.020","article-title":"Recurrence-free and 5-year survival following robotic-assisted surgical staging for endometrial carcinoma","volume":"129","author":"Kilgore","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/IGC.0000000000000970","article-title":"Prediction of site-specific tumor relapses in patients with stage IYII endometrioid endometrial cancer","volume":"27","author":"Tuomi","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/gyno.1994.1158","article-title":"Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma","volume":"54","author":"Lee","year":"1994","journal-title":"Gynecol Oncol"},{"key":"R7-20261009","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer\u2014a pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PGP.0b013e31829c6757","article-title":"Risk factors for recurrence and prognosis of low-grade endometrial adenocarcinoma; vaginal versus other sites","volume":"33","author":"Moschiano","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20261009","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2019.04.676","article-title":"Recurrent early stage endometrial cancer: patterns of recurrence and results of salvage therapy","volume":"154","author":"Francis","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejca.2016.09.033","article-title":"The nature of early-stage endometrial cancer recurrence\u2014a national cohort study","volume":"69","author":"Jeppesen","year":"2016","journal-title":"Eur J Cancer"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0090-8258(03)00126-4","article-title":"Survival after relapse in patients with endometrial cancer: results from a randomized trial","volume":"89","author":"Creutzberg","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/PGP.0b013e31823ff422","article-title":"Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion","volume":"31","author":"Quick","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"243.e1","DOI":"10.1016\/j.ajog.2019.04.038","article-title":"Does surgical platform impact recurrence and survival? A study of utilization of multiport, single-port, and robotic-assisted laparoscopy in endometrial cancer surgery","volume":"221","author":"Chambers","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2023.10.011","article-title":"Isolated vaginal recurrence in women with stage I endometrial cancer","volume":"179","author":"Rios-Doria","year":"2023","journal-title":"Gynecol Oncol"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.1158\/1078-0432.CCR-23-1397","article-title":"Clinical behavior and molecular landscape of stage I p53-abnormal low-grade endometrioid endometrial carcinomas","volume":"29","author":"Jamieson","year":"2023","journal-title":"Clin Cancer Res"},{"key":"R16-20261009","first-page":"241","article-title":"Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate","volume":"248","author":"Sorbe","year":"2013","journal-title":"Brachytherapy"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:01:34Z","timestamp":1791558094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001195","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2026-04-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}